Leonard A Oppenheim
CIK 1307647 · last filed 2022-01-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$38.0K
Companies
4
Total Filings
42
Lifetime Open-Market Net
-$101.3K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| XTI Aerospace, Inc. (INPX) Delisted | Director | 0 | $5.27 | $0 | $0 | 7 | 2022-01-10 |
| XTI Aerospace, Inc. (SYRX) Delisted | Director | 6,812 | — | — | $0 | 10 | 2017-02-07 |
| SEELOS THERAPEUTICS, INC. (APRI) Delisted | Director | 682 | — | — | -$37.9K | 9 | 2014-02-10 |
| NEXM | Director | 16,104 | $2.36 | $38.0K | -$63.4K | 15 | 2010-04-01 |
Recent Filings · Page 2 of 5
42 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-02-16 | XTI Aerospace, Inc. (SYRX) Delisted | Grant (A) | +5,000 | $0 | EDGAR |
| 2015-10-05 | XTI Aerospace, Inc. (SYRX) Delisted | Grant (A) | +5,000 | $0 | EDGAR |
| 2015-09-14 | XTI Aerospace, Inc. (SYRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-07-24 | XTI Aerospace, Inc. (SYRX) Delisted | Grant (A) | +5,000 | $0 | EDGAR |
| 2015-05-01 | XTI Aerospace, Inc. (SYRX) Delisted | Grant (A) | +5,000 | $0 | EDGAR |
| 2015-02-03 | XTI Aerospace, Inc. (SYRX) Delisted | Grant (A) | +5,000 | $0 | EDGAR |
| 2014-10-31 | XTI Aerospace, Inc. (SYRX) Delisted | Grant (A) | +8,572 | $0 | EDGAR |
| 2014-02-10 | SEELOS THERAPEUTICS, INC. (APRI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-01-06 | SEELOS THERAPEUTICS, INC. (APRI) Delisted | Mixed | −15,212 | -$37.9K | EDGAR |
| 2013-01-08 | SEELOS THERAPEUTICS, INC. (APRI) Delisted | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.